Defect-engineered magnetic bismuth nanomedicine for dual-modal imaging and synergistic lung tumor therapy
Materials Today Bio · 2025-06 · 32 · 101680
DOI: 10.1016/j.mtbio.2025.101680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2025-06. Verfasst von Pengpeng Jia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Henan Normal University.
Abstract (Originalsprache)
Bismuth sulfide (Bi2S3) nanomaterials are recognized for their potential in tumor therapy due to their narrow bandgap and low toxicity. However, limited photothermal conversion efficiency (PCE) and low carrier density restrict their broader application in photothermal cancer treatment. To address these challenges, we designed defect-engineered, magnetic-targeting Bi2S3-based photothermal nanoparticles, Fe3O4@Au@Bi2S3 nanorugbys (Fe3O4@Au@Bi2S3 NRs). These nanoparticles were developed using a layer-by-layer encapsulation strategy with sulfur vacancies (Vs) and Bi antisite defects (Bi replacing S, Bis), enhancing electron trapping and recombination to boost the near-infrared (NIR) response. The PCE of Fe3O4@Au@Bi2S3 NRs reached 44.34 %, which significantly improved their efficacy in photothermal treatment for lung tumors. Moreover, the polyvinylpyrrolidone (PVP) coating on the nanoparticles enabled efficient loading and pH-responsive release of doxorubicin hydrochloride (DOX), facilitating synergistic chemo-photothermal therapy. When exposed to an external magnetic field, the nanoparticles demonstrated strong magnetic targeting and enhanced computed tomography (CT) imaging capabilities, improving tumor treatment accuracy. Both in vitro and in vivo studies showed that this combined therapy effectively induced cancer cell apoptosis and inhibited tumor proliferation, showcasing outstanding anti-tumor performance. This study provides a promising strategy for enhancing chemo-photothermal therapy through defect-engineered, magnetic-targeted Fe3O4@Au@Bi2S3 nanoparticles, holding significant potential for clinical applications in tumor therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
- USST-UH International Joint Laboratory for Tumor Diagnosis and Energy Treatment, University of Shanghai for Science and Technology, Shanghai, 200093, China.
- Collaborative Innovation Centre of Henan Province for Green Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Henan Engineering Research Centre of Chiral Hydro…
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China.
- Cancer Institute, Tongji University School of Medicine, Shanghai, 200092, China.
Förderung
- Henan Normal University
Zitieren
APA
Jia, P., Tu, J., Shen, H., Jiang, Y., Zhang, Q., Xue, W., Liu, M., Liu, J., Miao, Y., Ouyang, R., & Zhou, S. (2025). Defect-engineered magnetic bismuth nanomedicine for dual-modal imaging and synergistic lung tumor therapy. Materials Today Bio, 32, 101680. https://doi.org/10.1016/j.mtbio.2025.101680
Vancouver
Jia P, Tu J, Shen H, Jiang Y, Zhang Q, Xue W, et al. Defect-engineered magnetic bismuth nanomedicine for dual-modal imaging and synergistic lung tumor therapy. Materials Today Bio. 2025;32:101680. doi:10.1016/j.mtbio.2025.101680
BibTeX
@article{Jia2025,
author = {Jia, Pengpeng and Tu, Jie and Shen, Hongyu and Jiang, Yuqin and Zhang, Qiupeng and Xue, Weixian and Liu, Meitong and Liu, Jianbo and Miao, Yuqing and Ouyang, Ruizhuo and Zhou, Shuang},
title = {Defect-engineered magnetic bismuth nanomedicine for dual-modal imaging and synergistic lung tumor therapy},
journal = {Materials Today Bio},
year = {2025},
volume = {32},
pages = {101680},
doi = {10.1016/j.mtbio.2025.101680}
}
EUVIMED